Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Pádraig O'Sullivan .
Filed returns
463
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2022 | Autism Spectrum Information, Advice and Meeting Point Ltd, Trading as AsIAm | Health | Engaged with a range of stakeholders in promoting our World Autism Month Campaign which included the publication of the Same Chance Report (Public policy or programme) | 18 | On lobbying.ie |
| Jan–Apr 2022 | Autism Spectrum Information, Advice and Meeting Point Ltd, Trading as AsIAm | Health | Supported the establishment of the Joint Oireachtas Committee on Autism (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2022 | BioMarin International Limited | Health | Rare disease policy in Ireland and EU (Public policy or programme) | 43 | On lobbying.ie |
| Jan–Apr 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 10 | On lobbying.ie |
| Jan–Apr 2022 | MSD | Health | Oncology Policy (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2022 | Irish Pharmaceutical Healthcare Association | Health | (i) EU Pharmaceutical Policy; (ii) EFPIA WAIT Indicator Survey - Access to new medicines; (iii) Access to Orphan Medicines; (iv) EU Pharmaceutical Strategy (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2022 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland and the EU (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2022 | Takeda Products Ireland | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 8 | On lobbying.ie |
| Jan–Apr 2022 | Pfizer | Health | PMB in relation to reimbursement of orphan medicines Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021 (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2022 | Irish Platform for Patients' Organisations, Science and Industry | Health | Meeting with the Minister to discuss National Rare Disease Plan and other issues relevant to the rare disease community (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2022 | Illumina Cambridge Ltd | Health | National Genomics and Genetic Medicine Network (Public policy or programme) | 34 | On lobbying.ie |
| Jan–Apr 2022 | Fighting Blindness | Health | The HSE reimbursement of gene therapy 'Luxturna' (Matters involving public funds) | 5 | On lobbying.ie |
| Jan–Apr 2022 | Rare Diseases Ireland | Health | Follow up emails following Feb 24 meeting hosted by Padraig O'Sullivan (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2022 | Rare Diseases Ireland | Health | Meetings regarding amendment to Health (Pricing and Supply of Medical Goods) Act 2013 for orphan mediciens (Legislation) | 9 | On lobbying.ie |
| Jan–Apr 2022 | Pro Life Campaign | Health | Requested meetings with politicians to outline the Pro Life Campaign's objectives as part of the three year review of the Health (Regulation of Termination of Pregnancy) Act 2018 (Public policy or programme) | 34 | On lobbying.ie |
| Sep–Dec 2021 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss the cystic fibrosis in Ireland and access to innovative medicines in treating this and other serious diseases (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2021 | The Irish Farmers' Association - IFA | Health | Green Ribbon Walks 2021 - IFA's Let's Talk and Walk (Public policy or programme) | 54 | On lobbying.ie |
| Sep–Dec 2021 | Rare Diseases Ireland | Health | Health (Pricing and Supply of Medical Goods) Act 2013 - recommendations for changes and updates to existing legislation (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2021 | BioMarin International Limited | Health | Rare disease policy in Ireland and EU (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2021 | Instinctif Partners Public Affairs Ireland | Health | Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021 (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 4 | On lobbying.ie |
| Sep–Dec 2021 | Kyowa Kirin International | Health | Introduction to Kyowa Kirin International; Awareness raising of Lymphoma Awareness Month; Highlighting concerns around progress of Sláintecare (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2021 | Jack and Jill Children's Foundation | Health | Lobbied to get a particular drug called Slenyto covered under the Drug Hardship Scheme (Matters involving public funds) | 3 | On lobbying.ie |
| Sep–Dec 2021 | DHR Consultancy Limited | Health | Programme for Government commitment to roll out free contraception - activity from 1 September (Matters involving public funds) | 232 | On lobbying.ie |
| Sep–Dec 2021 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2021 | Illumina Cambridge Ltd | Health | National Genomics and Genetic Medicine Network (Public policy or programme) | 25 | On lobbying.ie |
| Sep–Dec 2021 | Neurological Alliance of Ireland | Health | Call for investment to address the shortfall in neurology nurse specialists across Ireland (Matters involving public funds) | 146 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Health | Sharing copy of a new report on Cell and Gene therapies (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 9 | On lobbying.ie |
| May–Aug 2021 | BioMarin International Limited | Health | Rare disease policy in Ireland and EU (Public policy or programme) | 19 | On lobbying.ie |
| May–Aug 2021 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 15 | On lobbying.ie |
| Jan–Apr 2021 | NCBI | Health | The expansion of the Eye Clinic Liaison Officer Service (ECLO's) to acute hospitals outside of Dublin (Public policy or programme) | 23 | On lobbying.ie |
| Jan–Apr 2021 | NCBI | Health | The expansion of the Eye Clinic Liaison Officer Service (ECLO's) to acute hospitals outside of Dublin (Public policy or programme) | 28 | On lobbying.ie |
| Jan–Apr 2021 | Instinctif Partners Public Affairs Ireland | Health | Discussion about eHealth policy in Ireland and the broader ecosystem (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2021 | Vulcan Consulting Limited | Health | Rare disease policy in Ireland (Public policy or programme) | 8 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| Jan–Apr 2021 | BioMarin International Limited | Health | Rare disease policy in Ireland (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2020 | Sage Advocacy | Health | Invite to the launch of new discussion document on the impact that the pandemic has had on the current system of care for older people. (Matters involving public funds) | 23 | On lobbying.ie |
| Sep–Dec 2020 | Sage Advocacy | Health | Covid 19 and nursing homes: To highlight that families who have loved ones in nursing homes had contacted Sage Advocacy to express their concerns about restrictions on visiting nursing home residents and to also… (Matters involving public funds) | 19 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 14 | On lobbying.ie |
| Sep–Dec 2020 | Irish Hospital Consultants Association | Health | Pre-budget submission concerning the 2021 health budget on increased capacity and resourcing needs of acute hospital and mental health services, recruitment and retention of consultants, and clinical indemnity. (Matters involving public funds) | 33 | On lobbying.ie |
| May–Aug 2020 | Multiple Sclerosis Ireland | Health | Put forward a submission to the Oireachtas Special Committee on COVID-19 Response with details of the challenges people living with MS are facing during the COVID-19 Pandemic and the issues MS Ireland are facing as a… (Public policy or programme) | 21 | On lobbying.ie |
| May–Aug 2020 | Responsible Vaping Ireland | Health | Educational memo on vaping products to all new Oireachtas members (Public policy or programme) | 66 | On lobbying.ie |
| May–Aug 2020 | Irish Council for Civil Liberties | Health | HSE Covid-19 Contact Tracing and Symptom Tracking App (Public policy or programme) | 20 | On lobbying.ie |
| May–Aug 2020 | Irish Cancer Society | Health | COVID-19 response (Public policy or programme) | 28 | On lobbying.ie |
| May–Aug 2020 | Irish Thoracic Society | Health | Submission to the Oireachtas Special Committee on COVID-19 Response regarding concerns regarding the impact of COVID-19 on respiratory healthcare services due to the respiratory effect of COVID-19 and due to the backlog… (Public policy or programme) | 21 | On lobbying.ie |
| May–Aug 2020 | Irish Medical Organisation | Health | Covid 19 Policy response - testing and tracing (Public policy or programme) | 24 | On lobbying.ie |
| May–Aug 2020 | Irish Medical Organisation | Health | Covid 19 Policy response - Protection of healthcare workers (Matters involving public funds) | 24 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 463 | 100.0% |